| Zebularine | Experimental | DERL1 | 79139 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of DERL1 mRNA | 8q24.13 | |
| Zebularine | Experimental | ESR1 | 2099 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of ESR1 mRNA | 6q25.1-q25.2 | |
| Zebularine | Experimental | HLA-DQB1 | 3119 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of HLA-DQB1 mRNA | 6p21.32 | |
| Zebularine | Experimental | LARP7 | 51574 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of LARP7 mRNA | 4q25 | |
| Zebularine | Experimental | MAP1A | 4130 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of MAP1A mRNA | 15q15.3 | |
| Zebularine | Experimental | MAPK8IP3 | 23162 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of MAPK8IP3 mRNA | 16p13.3 | |
| Zebularine | Experimental | MTRF1L | 54516 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of MTRF1L mRNA | 6q25.2 | |
| Zebularine | Experimental | NFATC2IP | 84901 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of NFATC2IP mRNA | 16p11.2 | |
| Zebularine | Experimental | NFIC | 4782 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of NFIC mRNA | 19p13.3 | |
| Zebularine | Experimental | PHLDB1 | 23187 |
downregulated | pyrimidin-2-one beta-ribofuranoside results in decreased expression of PHLDB1 mRNA | 11q23.3 | |
| Zebularine | Experimental | PML | 5371 |
downregulated | pyrimidin-2-one beta-ribofuranoside results in decreased expression of PML mRNA | 15q24.1 | |
| Zebularine | Experimental | RABGAP1L | 9910 |
downregulated | pyrimidin-2-one beta-ribofuranoside results in decreased expression of RABGAP1L mRNA | 1q25.1 | |
| Zebularine | Experimental | RBM34 | 23029 |
downregulated | pyrimidin-2-one beta-ribofuranoside results in decreased expression of RBM34 mRNA | 1q42.3 | |
| Zebularine | Experimental | RRM2B | 50484 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of RRM2B mRNA | 8q22.3 | |
| Zebularine | Experimental | S100P | 6286 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of S100P mRNA | 4p16.1 | |
| Zebularine | Experimental | SLA | 6503 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of SLA mRNA | 8q24.22 | |
| Zebularine | Experimental | SNIP1 | 79753 |
downregulated | pyrimidin-2-one beta-ribofuranoside results in decreased expression of SNIP1 mRNA | 1p34.3 | |
| Zebularine | Experimental | ST3GAL6 | 10402 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of ST3GAL6 mRNA | 3q12.1 | |
| Zebularine | Experimental | TFE3 | 7030 |
upregulated | pyrimidin-2-one beta-ribofuranoside results in increased expression of TFE3 mRNA | Xp11.23 | |
| Zebularine | Experimental | WDR47 | 22911 |
downregulated | pyrimidin-2-one beta-ribofuranoside results in decreased expression of WDR47 mRNA | 1p13.3 | |
| Pyrithione | Approved Investigational | ANXA5 | 308 |
upregulated | pyrithione zinc results in increased expression of ANXA5 mRNA | 4q27 | |
| Pyrithione | Approved Investigational | BAX | 581 |
upregulated | pyrithione zinc results in increased expression of BAX mRNA | 19q13.33 | |
| Pyrithione | Approved Investigational | BCL2L1 | 598 |
downregulated | pyrithione zinc results in decreased expression of BCL2L1 mRNA | 20q11.21 | |
| Pyrithione | Approved Investigational | CASP1 | 834 |
upregulated | pyrithione zinc results in increased expression of CASP1 mRNA | 11q22.3 | |
| Pyrithione | Approved Investigational | CASP8 | 841 |
upregulated | pyrithione zinc results in increased expression of CASP8 mRNA | 2q33.1 | |